Search
Now showing items 1-6 of 6
Engaging diverse communities participating in clinical trials: case examples from across Africa.
(University of Nairobi,, 2010)
BACKGROUND :In the advent of increasing international collaborative research involving participants drawn from populations with diverse cultural backgrounds, community engagement becomes very critical for the smooth ...
Safety and immunogenicity of the malaria vaccine candidate GMZ2 in malaria-exposed, adult individuals from Lambaréné, Gabon.
(University of Nairobi,, 2010)
Malaria is still one of the major public health threats in sub-Saharan Africa. An effective vaccine could be a sustainable control measure that can be integrated into existing health infrastructures. The malaria vaccine ...
Is vaccine the magic bullet for malaria elimination? A reality check.
(University of Nairobi,, 2010-12)
Malaria remains a major health burden especially for the developing countries. Despite concerted efforts at using the current control tools, such as bed nets, anti malarial drugs and vector control measures, the disease ...
Anticancer agents against malaria: time to revisit?
(University of Nairobi,, 2010-03)
The emergence of artemisinin resistance could adversely impact the current strategy for malaria treatment; thus, new drugs are urgently needed. A possible approach to developing new antimalarials is to find new uses for ...
Modulators of the efficacy and toxicity of drugs in malaria treatment.
(University of Nairobi,, 2010-06)
The burgeoning problem of drug resistance in malaria requires the urgent discovery of new drugs. Discovery of an antimalarial agent that fulfills the requirements of a mass-treatment drug is challenging. Such an antimalarial ...